China Neurovascular Devices Market Size & Outlook
China neurovascular devices market, 2018-2030 (US$M)
Related Markets
China neurovascular devices market highlights
- The China neurovascular devices market generated a revenue of USD 95.9 million in 2023 and is expected to reach USD 165.5 million by 2030.
- The China market is expected to grow at a CAGR of 8.1% from 2024 to 2030.
- In terms of segment, cerebral embolization and aneurysm coiling devices was the largest revenue generating device in 2023.
- Support Devices is the most lucrative device segment registering the fastest growth during the forecast period.
Neurovascular devices market data book summary
| Market revenue in 2023 | USD 95.9 million |
| Market revenue in 2030 | USD 165.5 million |
| Growth rate | 8.1% (CAGR from 2023 to 2030) |
| Largest segment | Cerebral embolization and aneurysm coiling devices |
| Fastest growing segment | Support Devices |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cerebral Embolization and aneurysm Coiling devices, Cerebral Angioplasty and Stenting Systems, Neurothrombectomy Devices, Support Devices, Trans Radial Access Devices |
| Key market players worldwide | Medtronic PLC, Johnson & Johnson, Penumbra Inc, MicroPort Scientific Corp, Stryker Corp, Terumo Corp, Integra Lifesciences Holdings Corp |
Other key industry trends
- In terms of revenue, China accounted for 3.2% of the global neurovascular devices market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan neurovascular devices market is projected to lead the regional market in terms of revenue in 2030.
- Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 212.2 million by 2030.
Cerebral embolization and aneurysm coiling devices was the largest segment with a revenue share of 34.83% in 2023. Horizon Databook has segmented the China neurovascular devices market based on cerebral embolization and aneurysm coiling devices, cerebral angioplasty and stenting systems, neurothrombectomy devices, support devices, trans radial access devices covering the revenue growth of each sub-segment from 2018 to 2030.
China neurovascular devices market is expected to witness considerable growth over the forecast period owing to an increase in the number of acute ischemic stroke cases and presence of several local & key players in the market.
For instance, as per an article published in AHA journal in 2018, stroke was one of the leading causes of death in China in recent years. As per a study published in Stroke and Vascular Neurology (BMJ), in 2018, the death rate of cerebrovascular diseases was 149.49 per 100,000 populations, accounting for around 1.57 million deaths.
The China Intracranial Aneurysm Project (ICAP) is an observational, prospective, and multicenter registry study of risks, rupture, diagnosis, and treatment of intracranial aneurysm. Five studies are under ICAP. The CIAP-1 is the observational study of Unruptured Intracranial Aneurysm (UIA).
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Neurovascular Devices Market Scope
Neurovascular Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China neurovascular devices market size, by device, 2018-2030 (US$M)
China Neurovascular Devices Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
